Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Expert Review of Vaccines
|
November 12, 2022
The role of bactericidal and opsonic activity in immunity against Bordetella pertussis
Pascal Blanc, Yuanqing Liu, Nathalie Reveneau, et al.
Emerging Microbes & Infections
|
May 10, 2018
Bordetella pertussis isolates vary in their interactions with human complement components
Charlotte Brookes, Irene Freire-Martin, Breeze Cavell, et al.
Vaccines
|
June 25, 2026
Development of High-Throughput Serum Bactericidal Assays for <i>Bordetella pertussis</i> to Evaluate BPZE1
Peter Goldstein, Tania Gensale, Shannon Harris, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
November 16, 2021
Generation of a Universal Human Complement Source by Large-Scale Depletion of IgG and IgM from Pooled Human Plasma
Frances Alexander, Emily Brunt, Holly Humphries, et al.
Lancet (London, England)
|
March 11, 2023
Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus-diphtheria-acellular pertussis vaccine: a randomised, double-blind, phase 2b trial
Cheryl Keech, Vicki E Miller, Barbara Rizzardi, et al.
JAMA Network Open
|
December 1, 2025
Global Incidence of Pertussis After the COVID-19 Pandemic
Andrew Gorringe, Breeze Cavell, Frank Beard, et al.
The Lancet. Infectious Diseases
|
March 28, 2025
The effect of pertussis vaccination in pregnancy on the immunogenicity of acellular or whole-cell pertussis vaccination in Gambian infants (GaPS): a single-centre, randomised, controlled, double-blind, phase 4 trial
Anja Saso, Ebrima Kanteh, David Jeffries, et al.
The Pediatric Infectious Disease Journal
|
February 14, 2025
Maternal and Placental Antibody Responses in SARS-CoV-2 Vaccination and Natural Infection During Pregnancy
Sarah Sturrock, Breeze Cavell, Frances Alexander, et al.
Nature Medicine
|
December 18, 2020
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Jordan R Barrett, Sandra Belij-Rammerstorfer, Christina Dold, et al.
Nature Communications
|
March 11, 2022
Divergent trajectories of antiviral memory after SARS-CoV-2 infection
Adriana Tomic, Donal T Skelly, Ane Ogbe, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Expert Review of Vaccines
|
November 12, 2022
The role of bactericidal and opsonic activity in immunity against Bordetella pertussis
Pascal Blanc, Yuanqing Liu, Nathalie Reveneau, et al.
Emerging Microbes & Infections
|
May 10, 2018
Bordetella pertussis isolates vary in their interactions with human complement components
Charlotte Brookes, Irene Freire-Martin, Breeze Cavell, et al.
Vaccines
|
June 25, 2026
Development of High-Throughput Serum Bactericidal Assays for <i>Bordetella pertussis</i> to Evaluate BPZE1
Peter Goldstein, Tania Gensale, Shannon Harris, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
November 16, 2021
Generation of a Universal Human Complement Source by Large-Scale Depletion of IgG and IgM from Pooled Human Plasma
Frances Alexander, Emily Brunt, Holly Humphries, et al.
Lancet (London, England)
|
March 11, 2023
Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus-diphtheria-acellular pertussis vaccine: a randomised, double-blind, phase 2b trial
Cheryl Keech, Vicki E Miller, Barbara Rizzardi, et al.
JAMA Network Open
|
December 1, 2025
Global Incidence of Pertussis After the COVID-19 Pandemic
Andrew Gorringe, Breeze Cavell, Frank Beard, et al.
The Lancet. Infectious Diseases
|
March 28, 2025
The effect of pertussis vaccination in pregnancy on the immunogenicity of acellular or whole-cell pertussis vaccination in Gambian infants (GaPS): a single-centre, randomised, controlled, double-blind, phase 4 trial
Anja Saso, Ebrima Kanteh, David Jeffries, et al.
The Pediatric Infectious Disease Journal
|
February 14, 2025
Maternal and Placental Antibody Responses in SARS-CoV-2 Vaccination and Natural Infection During Pregnancy
Sarah Sturrock, Breeze Cavell, Frances Alexander, et al.
Nature Medicine
|
December 18, 2020
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Jordan R Barrett, Sandra Belij-Rammerstorfer, Christina Dold, et al.
Nature Communications
|
March 11, 2022
Divergent trajectories of antiviral memory after SARS-CoV-2 infection
Adriana Tomic, Donal T Skelly, Ane Ogbe, et al.
Page
of 1